Zynerba Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ZYNE and buy or sell other stocks, ETFs, and their options commission-free!About ZYNE
Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on the research and development of rare and near-rare neuropsychiatric conditions.
CEOArmando Anido, MBA
CEOArmando Anido, MBA
Employees—
Employees—
HeadquartersDevon, Pennsylvania
HeadquartersDevon, Pennsylvania
Founded2007
Founded2007
Employees—
Employees—
ZYNE Key Statistics
Market cap70.12M
Market cap70.12M
Price-Earnings ratio-1.63
Price-Earnings ratio-1.63
Dividend yield—
Dividend yield—
Average volume585.87K
Average volume585.87K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.40
52 Week high$1.40
52 Week low$0.25
52 Week low$0.25
Stock Snapshot
As of today, Zynerba Pharmaceuticals(ZYNE) shares are valued at $1.30. The company's market cap stands at 70.12M, with a P/E ratio of -1.63.
Zynerba Pharmaceuticals(ZYNE) stock opened on 2025-12-19 at —. The price climbed to — and dipped to —.
Zynerba Pharmaceuticals(ZYNE) shares are trading with a volume of 0, against a daily average of 585.87K.
During the past year, Zynerba Pharmaceuticals(ZYNE) stock moved between $0.25 at its lowest and $1.40 at its peak.
During the past year, Zynerba Pharmaceuticals(ZYNE) stock moved between $0.25 at its lowest and $1.40 at its peak.
People also own
Based on the portfolios of people who own ZYNE. This list is generated using Robinhood data, and it’s not a recommendation.